Back to search
Immune-Related Adverse Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Related Adverse Events trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Related Adverse Events trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The introduction of immune checkpoint inhibitors (immunotherapy) that stimulate our immune system to recognize and attack cancer cells has been one of the most…
This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying rese…
This trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart failure events in participants with diffuse…
The primary aim of this study is to evaluate the feasibility of a supervised high intensity interval training (HIIT) program during first-line dual immune check…
Background and Study Rationale Immune checkpoint inhibitors (ICI) are a breakthrough cancer treatment that boosts the immune system to fight tumors. While effec…
Primary Objective: To evaluate the effectiveness of Thymosin Alpha-1 combined with PD-1 monoclonal antibody in elderly patients with advanced melanoma . Secon…
The overall aim of the study is to determine the clinical efficacy and mechanisms of action of anti-IL-4a (dupilumab) as treatment for patients with Chronic Rhi…
This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in…